Weifang Tang

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

Ying Cheng, Yi-long Wu, B. Han, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

CXCR 4 / RhoA signaling pathway is involved in miR-128-regulated proliferation and apoptosis of human thyroid cancer cells

Xucai Zheng, Song Liu, Yuanyuan Zhao, 2017 .

Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway

Juan Yan, Ying Huang, C. Yi, 2021, Oncology Letters.

Racial Disparities in Survival of Breast Cancer Patients After Surgery

Shuhan Wang, Weifang Tang, Shengying Wang, 2022, Frontiers in Public Health.

Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning

Yefeng Zheng, Guihua Chen, Kai Ma, 2020, Journal of Cancer Research and Clinical Oncology.

Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy

Xucai Zheng, Song Liu, Yuanyuan Zhao, 2017, Medicine.

Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma

J. Liu, Xucai Zheng, Shengying Wang, 2023, Endocrine.

GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation

Shikai Hong, Weifang Tang, Yuan Gao, 2024, BMC cancer.